ClinicalTrials.govpublic full text
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
systemic lupus erythematosus, dapirolizumab pegol, sle, dzp, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 834732
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.